Diterpenoid DGT alleviates atopic dermatitis–like responses in vitro and in vivo via targeting IL-4Rα
DGT's potent anti-inflammatory effects and good safety profile suggest that it is a potential candidate for the treatment of atopic dermatitis.
Authors
- Yunhui Yu
- Jingjing Gao (ORCID: https://orcid.org/0000-0001-8608-6949)
- Fei Yang (ORCID: https://orcid.org/0000-0002-2156-4193)
- Biyan Zhang (ORCID: https://orcid.org/0000-0003-0329-2451)
- Xiaoqiang Zhu (ORCID: https://orcid.org/0000-0002-1980-0142)
- Dong Li (ORCID: https://orcid.org/0000-0002-6496-4605)
- Mingming Hu (ORCID: https://orcid.org/0000-0002-6626-9657)
- Qing Xie (ORCID: https://orcid.org/0000-0002-4084-0325)
- Zijun Chen (ORCID: https://orcid.org/0000-0002-4450-8645)
- Yanping Wang (ORCID: https://orcid.org/0000-0001-9395-1128)
- Haimei Feng
- Yunsen Li (ORCID: https://orcid.org/0009-0006-5441-151X)
- Zhangyang Feng
Institutions
- Soochow University (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- Ascepion Pharmaceuticals (China) (CN)
- Suzhou Municipal Hospital (CN)
Publication Details
- Journal
- Biomedicine & Pharmacotherapy
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1016/j.biopha.2024.117321
- Citations
- 4
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.14